Protalix BioTherapeutics Inc. (PLX)

Jun 09, 2026

PLX Q1 2026 Earnings: EPS Rockets Past Estimates, Stock Edges LowerGuidance vs Actual - newsline.com

Jun 09, 2026

Jun 03, 2026

Protalix BioTherapeutics (PLX) Holds Near Key Support After Mild DeclineZero Lag EMA - newsline.com

Jun 03, 2026

May 28, 2026

Protalix BioTherapeutics (PLX) Holds Near Support After Modest DeclinePut Dominated - thelegaladvocate.com

May 28, 2026

May 28, 2026

Protalix BioTherapeutics (PLX) Consolidates Near Support After Mild DeclineCombination Correction - newsline.com

May 28, 2026

May 27, 2026

H.C. Wainwright Maintains Protalix Biotherapeutics(PLX.US) With Buy Rating, Maintains Target Price $12 - Moomoo

May 27, 2026

May 26, 2026

Protalix BioTherapeutics (PLX) Rises 1.43% as Biotech Stock Tests Key ResistancePrice Gap Fill - The Legal Advocate

May 26, 2026

May 26, 2026

3 Penny Stocks With Market Caps Larger Than $100M To Consider - Sahm

May 26, 2026

May 23, 2026

PLX Q1 2026 Earnings: Massive EPS Surprise as Protalix BioTherapeutics Reports Strong ProfitabilityRevenue Growth Outlook - The Legal Advocate

May 23, 2026

May 22, 2026

PLX Stock Price, Quote & Chart | PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) - ChartMill

May 22, 2026

May 21, 2026

Protalix Highlights Elfabrio Dosing Approvals and Growth Plans - TipRanks

May 21, 2026

May 21, 2026

Protalix BioTherapeutics Advances Rare Disease Treatments with Elfabrio® and PRX-115, Achieves Key Regulatory and Pipeline Milestones - Minichart

May 21, 2026

May 21, 2026

Protalix BioTherapeutics (PLX) posts new May 2026 corporate presentation for investors - Stock Titan

May 21, 2026

May 18, 2026

Protalix BioTherapeutics appoints Gilad Mamlok as CFO - MSN

May 18, 2026

May 16, 2026

Protalix BioTherapeutics (PLX) Q1 2026 8-K: EPS Not Disclosed, R - GuruFocus

May 16, 2026

May 15, 2026

Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone - MSN

May 15, 2026

May 14, 2026

Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets - The Globe and Mail

May 14, 2026

May 14, 2026

PLX: Chiesi milestone received - MSN

May 14, 2026

May 14, 2026

PLX: Chiesi Milestone Received - Yahoo Finance

May 14, 2026

May 14, 2026

Protalix BioTherapeutics 1Q Rev $33.8M >PLX - Moomoo

May 14, 2026

May 14, 2026

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026

May 14, 2026

Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results - Sahm

May 14, 2026

May 14, 2026

Protalix BioTherapeutics Inc (PLX) Q1 2026 Earnings Call Highlights: Strong Financial Position ... By GuruFocus - Investing.com Canada

May 14, 2026

May 14, 2026

Protalix BioTherapeutics, Inc. Q1 2026 Financial Results & SEC 10-Q Filing Overview - Minichart

May 14, 2026

May 13, 2026

Protalix BioTherapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 13, 2026

May 13, 2026

Protalix BioTherapeutics Inc (PLX) Q1 2026 Earnings Call Highlig - GuruFocus

May 13, 2026

May 13, 2026

Protalix BioTherapeutics Delivers 234% Revenue Growth in Q1 2026 - AlphaStreet

May 13, 2026

May 13, 2026

Protalix BioTherapeutics Releases Q1 2026 Financial Results - AlphaStreet

May 13, 2026

May 13, 2026

Protalix BioTherapeutics Reports Q1 2026 Results: $18.3M Net Income, $25M Milestone From Chiesi, and Strong Guidance for 2026 - Minichart

May 13, 2026

May 13, 2026

Protalix BioTherapeutics Backs 2026 Rev $78M-$83M >PLX - Moomoo

May 13, 2026

May 13, 2026

Protalix BioTherapeutics (PLX) Reports Q1 Earnings with Strong R - GuruFocus

May 13, 2026

May 13, 2026

Earnings call transcript: Protalix Q1 2026: Earnings beat expectations, stock rises By Investing.com - Investing.com South Africa

May 13, 2026

May 13, 2026

PLX: $25M milestone drives strong Q1, with 2026 guidance reaffirmed and pipeline advancing - TradingView

May 13, 2026

May 13, 2026

Earnings call transcript: Protalix Q1 2026: Earnings beat expectations, stock rises - Investing.com

May 13, 2026

May 13, 2026

Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call - Yahoo Finance

May 13, 2026

May 13, 2026

Protalix BioTherapeutics 1Q 2026: Revenue $33.75M, Net income $18.32M, EPS $0.22— 10-Q Summary - TradingView

May 13, 2026

May 13, 2026

Protalix Hits Profitability, Fuels Pipeline with Elfabrio Milestone - BriefGlance

May 13, 2026

May 13, 2026

Protalix (PLX) turns Q1 2026 profit as Elfabrio EU milestone boosts cash - Stock Titan

May 13, 2026

May 13, 2026

Protalix reports Q1 2026 net income $18.3M on $33.8M revenue, $25M Chiesi milestone - TradingView

May 13, 2026

May 13, 2026

Protalix: Q1 Earnings Snapshot - marketscreener.com

May 13, 2026

May 13, 2026

BRIEF-Protalix BioTherapeutics Q1 EPS USD 0.23 - TradingView

May 13, 2026

May 13, 2026

Press Release: Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results - Moomoo

May 13, 2026

May 13, 2026

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 - Barchart.com

May 13, 2026

May 12, 2026

Protalix BioTherapeutics Q1 earnings preview - MSN

May 12, 2026

May 10, 2026

Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors? - MSN

May 10, 2026

May 07, 2026

Earnings Preview: PLX to Report Financial Results Pre-market on May 13 - Moomoo

May 07, 2026

May 06, 2026

Protalix to discuss quarterly results and business update May 13 - Stock Titan

May 06, 2026

May 01, 2026

MSN Money - MSN

May 01, 2026

Apr 30, 2026

Protalix BioTherapeutics (PLX) sets 2026 director, pay and stock plan votes - Stock Titan

Apr 30, 2026

Apr 30, 2026

[ARS] Protalix BioTherapeutics, Inc. SEC Filing - Stock Titan

Apr 30, 2026

Apr 27, 2026

Protalix says EU panel recommended a new dosing regimen for Fabry disease therapy - MSN

Apr 27, 2026

Apr 27, 2026

Protalix CFO updates Form 3 share and option holdings | PLX Insider Trading - Stock Titan

Apr 27, 2026